Compare AbCellera Biologics Inc (ABCL) vs SkyWest Inc (SKYW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs SkyWest Inc — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while SkyWest Inc trades at $108.98 (market cap $4.19B). The key difference: SkyWest Inc is the larger of the two by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, SkyWest Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | SKYW | |
|---|---|---|
Market Cap | $2.99B | $4.19B |
Sector | Health | Technology |
52-Week High | $9.76 | $123.72 |
52-Week Low | $2.78 | $78.40 |
Enterprise Value | $2.58B | $5.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About SkyWest Inc
SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →
